Ушбу иш иқтибос қилган ишлар

74 та иш

Иш: Resveratrol in oral cancer: a systematic review of preclinical studies on its anticancer mechanisms and therapeutic potential

1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

   Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt +23

   Мақола202155 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.080154

2. SYRCLE’s risk of bias tool for animal studies

   Carlijn R. Hooijmans, Maroeska M. Rovers, Rob BM de Vries +3

   Мақола20144 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138229

3. Autophagy and autophagy-related proteins in cancer

   Xiaohua Li, Shikun He, Binyun Ma

   Шарҳ мақола20204 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138248

4. Resveratrol (3,5,4′-trihydroxystilbene) and its properties in oral diseases

   D. Perrone, Maria Pia Fuggetta, Fatima Ardito +5

   Мақола20173 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138236

5. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges

   Chin-Yap Loh, Jian Chai, Ting Tang +5

   Шарҳ мақола20193 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138246

6. Resveratrol for cancer therapy: Challenges and future perspectives

   Boxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu +8

   Шарҳ мақола20213 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138253

7. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment

   Sahar Mafi, Behzad Mansoori, Shahram Taeb +4

   Шарҳ мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.003226

8. Chemotherapy-Induced Tissue Injury: An Insight into the Role of Extracellular Vesicles-Mediated Oxidative Stress Responses

   Chontida Yarana, Daret St. Clair

   Шарҳ мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138237

9. Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages

   Rajalaxmi Pradhan, Subhajit Chatterjee, Krushna Chandra Hembram +3

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.138250

10. Inflammation and tumor progression: signaling pathways and targeted intervention

    Huakan Zhao, Lei Wu, Guifang Yan +4

    Мақола20212 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138257

11. Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review

    Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile Teklemariam +2

    Шарҳ мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138264

12. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

    Shanna Qian, Zhong Wei, Wanting Yang +3

    Шарҳ мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138269

13. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway

    Rajalaxmi Pradhan, Subarno Paul, Biswajit Das +4

    Мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138271

14. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment

    Aranka Brockmueller, Sosmitha Girisa, Ajaikumar B. Kunnumakkara +1

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138273

15. Regulation of the Notch signaling pathway by natural products for cancer therapy

    Jiayi Cai, Yajie Qiao, Lingbin Chen +2

    Шарҳ мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138277

16. Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions

    Lolita Kuršvietienė, Dalia M. Kopustinskienė, Inga Stanevičienė +4

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138279

17. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

    Yamei Hu, Zigang Dong, Kangdong Liu

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138283

18. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons

    Seyed Aria Nejadghaderi, Maryam Balibegloo, Nima Rezaei

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138287

19. The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens

    Eduarda Ribeiro, Nuno Vale

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138289

20. Oral cancer: Recent breakthroughs in pathology and therapeutic approaches

    Surekha Ramachandran

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138290

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138221

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138222

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138223

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138224

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.138225